David Gallo

3.8k total citations
47 papers, 3.1k citations indexed

About

David Gallo is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, David Gallo has authored 47 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 13 papers in Pediatrics, Perinatology and Child Health and 9 papers in Immunology. Recurrent topics in David Gallo's work include Heme Oxygenase-1 and Carbon Monoxide (26 papers), Neonatal Health and Biochemistry (13 papers) and Immune Response and Inflammation (7 papers). David Gallo is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (26 papers), Neonatal Health and Biochemistry (13 papers) and Immune Response and Inflammation (7 papers). David Gallo collaborates with scholars based in United States, Spain and Portugal. David Gallo's co-authors include Leo E. Otterbein, Barbara Wegiel, Eva Csizmadia, Brian S. Zuckerbraun, Timothy R. Billiar, Clair Harris, Beek Yoke Chin, Mitchell P. Fink, Yoram Vodovotz and Fang Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

David Gallo

43 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gallo United States 27 1.9k 587 475 457 366 47 3.1k
Barbara Wegiel United States 34 2.4k 1.3× 756 1.3× 534 1.1× 392 0.9× 203 0.6× 55 3.5k
Mark Wysk United States 13 2.5k 1.3× 511 0.9× 415 0.9× 457 1.0× 153 0.4× 14 3.2k
Benito Yard Germany 40 1.3k 0.7× 231 0.4× 482 1.0× 820 1.8× 270 0.7× 190 5.0k
Edith Tzeng United States 31 1.5k 0.8× 203 0.3× 224 0.5× 362 0.8× 192 0.5× 87 3.2k
Pierre Hardy Canada 37 1.5k 0.8× 518 0.9× 154 0.3× 375 0.8× 218 0.6× 111 3.8k
Shinsuke Nakagawa Japan 23 845 0.4× 160 0.3× 211 0.4× 153 0.3× 170 0.5× 45 2.9k
Jose Luis García‐Giménez Spain 34 1.7k 0.9× 133 0.2× 154 0.3× 313 0.7× 282 0.8× 115 3.3k
Albert Amberger Austria 32 1.9k 1.0× 118 0.2× 250 0.5× 1.1k 2.3× 309 0.8× 81 4.0k
Chia‐Jung Li Taiwan 32 1.6k 0.8× 129 0.2× 111 0.2× 460 1.0× 390 1.1× 130 4.0k
Matthias Kapturczak United States 18 1.2k 0.6× 181 0.3× 117 0.2× 281 0.6× 125 0.3× 27 2.3k

Countries citing papers authored by David Gallo

Since Specialization
Citations

This map shows the geographic impact of David Gallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gallo more than expected).

Fields of papers citing papers by David Gallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gallo. The network helps show where David Gallo may publish in the future.

Co-authorship network of co-authors of David Gallo

This figure shows the co-authorship network connecting the top 25 collaborators of David Gallo. A scholar is included among the top collaborators of David Gallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gallo. David Gallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abad, Clemer, et al.. (2025). Cutaneous squamous cell carcinoma rechallenge with pembrolizumab. 3. 100707–100707.
2.
Souza, Rodrigo Wagner Alves de, Vanessa Azevedo Voltarelli, David Gallo, et al.. (2024). Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity. Journal of the American Heart Association. 13(9). e032067–e032067. 1 indexed citations
3.
4.
Souza, Rodrigo Wagner Alves de, David Gallo, Ghee Rye Lee, et al.. (2021). Skeletal muscle heme oxygenase-1 activity regulates aerobic capacity. Cell Reports. 35(3). 109018–109018. 26 indexed citations
5.
Lee, Ghee Rye, David Gallo, Rodrigo Wagner Alves de Souza, et al.. (2021). Trauma-induced heme release increases susceptibility to bacterial infection. JCI Insight. 6(20). 20 indexed citations
6.
Hanidziar, Dusan, David Gallo, Joshua Keegan, et al.. (2020). Characterization of pulmonary immune responses to hyperoxia by high-dimensional mass cytometry analyses. Scientific Reports. 10(1). 4677–4677. 14 indexed citations
7.
Belcher, John D., Edward D. Gomperts, Julia Nguyen, et al.. (2018). Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia. PLoS ONE. 13(10). e0205194–e0205194. 43 indexed citations
8.
Zheng, Yueqin, Xingyue Ji, Bingchen Yu, et al.. (2018). Enrichment-triggered prodrug activation demonstrated through mitochondria-targeted delivery of doxorubicin and carbon monoxide. Nature Chemistry. 10(7). 787–794. 265 indexed citations
9.
Li, Mailin, David Gallo, Eva Csizmadia, Leo E. Otterbein, & Barbara Wegiel. (2014). Carbon monoxide induces chromatin remodelling to facilitate endothelial cell migration. Thrombosis and Haemostasis. 112(5). 951–959. 19 indexed citations
10.
Nassour, Ibrahim, Benjamin Kautza, Daniel Escobar, et al.. (2014). Carbon Monoxide Protects Against Hemorrhagic Shock and Resuscitation–Induced Microcirculatory Injury and Tissue Injury. Shock. 43(2). 166–171. 23 indexed citations
11.
Wegiel, Barbara, Andreas Hedblom, David Gallo, et al.. (2014). Heme oxygenase-1 derived carbon monoxide permits maturation of myeloid cells. Cell Death and Disease. 5(3). e1139–e1139. 62 indexed citations
12.
Wegiel, Barbara, David Gallo, Eva Csizmadia, et al.. (2013). Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth. Cancer Research. 73(23). 7009–7021. 324 indexed citations
13.
Seixas, João, Abhik Mukhopadhyay, Teresa Santos‐Silva, et al.. (2012). Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics. Dalton Transactions. 42(17). 5985–5998. 63 indexed citations
14.
Hanto, Douglas W., Tiina Mäki, Myung Hee Yoon, et al.. (2010). Intraoperative Administration of Inhaled Carbon Monoxide Reduces Delayed Graft Function in Kidney Allografts in Swine. American Journal of Transplantation. 10(11). 2421–2430. 46 indexed citations
15.
Wegiel, Barbara, Catherine J. Baty, David Gallo, et al.. (2009). Cell Surface Biliverdin Reductase Mediates Biliverdin-induced Anti-inflammatory Effects via Phosphatidylinositol 3-Kinase and Akt. Journal of Biological Chemistry. 284(32). 21369–21378. 94 indexed citations
16.
Ramlawi, Basel, Jeffrey R. Scott, Jun Feng, et al.. (2006). Inhaled Carbon Monoxide Prevents Graft-Induced Intimal Hyperplasia in Swine. Journal of Surgical Research. 138(1). 121–127. 17 indexed citations
17.
Liu, Fang, David Gallo, Atsunori Nakao, et al.. (2005). Biliverdin administration protects against endotoxin-induced acute lung injury in rats. American Journal of Physiology-Lung Cellular and Molecular Physiology. 289(6). L1131–L1137. 187 indexed citations
18.
Lagoa, Constantino, Yoram Vodovotz, Donna B. Stolz, et al.. (2005). The role of hepatic type 1 plasminogen activator inhibitor (PAI‐1) during murine hemorrhagic shock†. Hepatology. 42(2). 390–399. 26 indexed citations
19.
McCloskey, Carol A., Marina V. Kameneva, Arkady Uryash, David Gallo, & Timothy R. Billiar. (2004). TISSUE HYPOXIA ACTIVATES JNK IN THE LIVER DURING HEMORRHAGIC SHOCK. Shock. 22(4). 380–386. 56 indexed citations
20.
McCloskey, Carol A., Brian S. Zuckerbraun, David Gallo, Yoram Vodovotz, & Timothy R. Billiar. (2003). A Role for Angiotensin II in the Activation of Extracellular Signal-Regulated Kinases in the Liver During Hemorrhagic Shock. Shock. 20(4). 316–319. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Wegiel Breakdown of academic impact, for papers by Mark Wysk Breakdown of academic impact, for papers by Benito Yard Breakdown of academic impact, for papers by Edith Tzeng Breakdown of academic impact, for papers by Pierre Hardy Breakdown of academic impact, for papers by Shinsuke Nakagawa Breakdown of academic impact, for papers by Jose Luis García‐Giménez Breakdown of academic impact, for papers by Albert Amberger Breakdown of academic impact, for papers by Chia‐Jung Li Breakdown of academic impact, for papers by Matthias Kapturczak
Rankless by CCL
2026